Literature DB >> 2156110

Pretreatment of urine samples for the analysis of 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid using solid-phase extraction.

R C Parry1, L Nolan, R E Shirey, G D Wachob, D J Gisch.   

Abstract

An extraction and concentration procedure using a unique solid-phase extraction tube was developed for the analysis of 11-nor-delta 9-tetrahydrocannabinol-9-carboxylic acid in urine. Absolute and relative recoveries of the drug metabolite were found to be greater than 85% and 92%, respectively. The extraction procedure allows quantitation of the drug metabolite by GC/MS, HPLC with UV detection, or GC with flame ionization detection. The extraction procedure was verified with urine samples obtained from marijuana users as well as spiked urine samples.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2156110     DOI: 10.1093/jat/14.1.39

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  2 in total

1.  Detection and quantification of low concentrations of 11-nor-delta-9-tetrahydrocannabinol-9-carboxylic acid from minimal amounts of urine.

Authors:  F Musshoff; T Daldrup
Journal:  Int J Legal Med       Date:  1991       Impact factor: 2.686

2.  Seasonality of Kawasaki disease: a global perspective.

Authors:  Jane C Burns; Lauren Herzog; Olivia Fabri; Adriana H Tremoulet; Xavier Rodó; Ritei Uehara; David Burgner; Emelia Bainto; David Pierce; Mary Tyree; Daniel Cayan
Journal:  PLoS One       Date:  2013-09-18       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.